C

Chiang Mai University | Research Institute for Health Sciences

Research site

(Unclaimed)

Location

110 Inthawarorot Road, Chiang Mai, Chiang Mai, Thailand

Site insights

Top conditions

Top treatments

Doravirine

Rilpivirine

Islatravir

JNJ-53718678

Parent organization

This site is a part of Chiang Mai University

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 9 total trials

Locations recently updated

Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)

This is a single-group, open-label, multi-site study in pediatric participants with human immunodeficiency virus type 1 (HIV-1) infection, aged 4 wee...

Enrolling

Human Immunodeficiency Virus (HIV) Infection

Drug: Doravirine

Drug: DOR/3TC/TDF

Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)

The purpose of this study is to evaluate the efficacy, immunogenicity and safety of the 9vHPV vaccine in men 20 to 45 years of age. The primary hypot...

Active, not recruiting

Papillomavirus Infections

Biological: 9vHPV Vaccine

Other: Placebo (Saline for Injection)